ArticleChemistry & biodiversity2026
Antibacterial and Antibiofilm Efficacy of 2-Phenyl Ethyl Methyl Ether Against Multidrug-Resistant Klebsiella pneumoniae.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The rise of Klebsiella pneumoniae (Kp) as an MDR pathogen has become a pressing global health challenge, contributing to UTIs and Pneumonia. A major factor underlying its persistence and antibiotic resistance is its inherent ability to form protective biofilm matrices. This study explores a natural approach to combat Kp biofilms by leveraging the antibacterial potential of plant-derived essential oils. Among bioactive compounds, 2-Phenyl ethyl methyl ether, a constituent of kewda oil, appears as a viable option. Our investigation revealed that 2-PEME exhibits significant antibacterial activity against Kp with a MIC of 50 mM, and the clinical isolate was further confirmed by morphological and molecular characterization. Notably, at a sub-MIC concentration of 25 mM, 2-PEME disrupted biofilm formation, reducing biofilm biomass by 61.17% ± 3.75% and 59.30% ± 6.24% in Kp and MTCC-109, respectively. These findings were further corroborated through microscopic analysis, providing strong evidence of 2-PEME's biofilm-inhibiting potential. To elucidate the mechanism of action, molecular docking studies were performed, which predicted strong binding affinities between 2-PEME and key biofilm-associated and drug-resistant proteins in Kp. Cell viability assays conducted on HEK-293, 3T3L1, and L929 cell lines demonstrated no cytotoxic effects, confirming their viability as a safe alternative. Computational pharmacokinetic analysis further supported its drug-like properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.